Literature DB >> 16940801

Effect of culture conditions on the chemosensitivity of ovarian cancer cell lines.

Augusta Fernando1, Sharon Glaysher, Mark Conroy, Marcin Pekalski, Jason Smith, Louise A Knight, Federica Di Nicolantonio, Ian A Cree.   

Abstract

The aim of this study was to define the chemosensitivity profile of a series of human ovarian cancer cell lines representing the human primary ovarian tumours under altered culture conditions and to compare the results with those from tumour-derived cells. In this study, we used a standardized ATP-based tumour chemosensitivity assay to measure the activity of cytotoxics in the seven ovarian carcinoma cell lines and ovarian tumour-derived cells. The use of adherence-free polypropylene plates and a serum-free medium slowed down cell proliferation in all cell lines tested, mimicking the slow growth rate of solid tumours in this type of plastic. The seeding density was optimized for each cell line and was in the range of 2000-4000 cells/well. Heterogenous sensitivity to different cytotoxics was observed in the seven ovarian cancer cell lines tested in the ATP-based tumour chemosensitivity assay. The human ovarian carcinoma cell line, OVCA433, was found to be the most resistant cell line and 75% of the drugs showed an Index(SUM) above 300. Our results suggest that the use of appropriate culture conditions i.e. a serum-free culture environment, adherence-free growth and optimum seeding density can induce cell lines to behave more like tumour-derived cells in response to cytotoxic agents. On the basis of the comparison of chemosensitivity profiles of tumour-derived cells and cell lines derived from the corresponding tumour, a panel of cell lines can be selected. Such a panel could be used to screen and develop anticancer drugs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16940801     DOI: 10.1097/01.cad.0000224445.23953.d9

Source DB:  PubMed          Journal:  Anticancer Drugs        ISSN: 0959-4973            Impact factor:   2.248


  8 in total

1.  Reliability of tumor primary cultures as a model for drug response prediction: expression profiles comparison of tissues versus primary cultures from colorectal cancer patients.

Authors:  Gregory Lucien Bellot; Wei Han Tan; Ling Lee Tay; Dean Koh; Xueying Wang
Journal:  J Cancer Res Clin Oncol       Date:  2011-12-21       Impact factor: 4.553

2.  The effect of pentamidine on melanoma ex vivo.

Authors:  Jason Smith; Benjamin J Stewart; Sharon Glaysher; Katharine Peregrin; Louise A Knight; David J Weber; Ian A Cree
Journal:  Anticancer Drugs       Date:  2010-02       Impact factor: 2.248

3.  Molecular basis of chemosensitivity of platinum pre-treated ovarian cancer to chemotherapy.

Authors:  S Glaysher; F G Gabriel; P Johnson; M Polak; L A Knight; K Parker; M Poole; A Narayanan; I A Cree
Journal:  Br J Cancer       Date:  2010-08-10       Impact factor: 7.640

Review 4.  Modeling platinum sensitive and resistant high-grade serous ovarian cancer: development and applications of experimental systems.

Authors:  Paula Cunnea; Euan A Stronach
Journal:  Front Oncol       Date:  2014-04-17       Impact factor: 6.244

5.  Genetically engineered mouse models and human osteosarcoma.

Authors:  Alvin Jm Ng; Anthony J Mutsaers; Emma K Baker; Carl R Walkley
Journal:  Clin Sarcoma Res       Date:  2012-10-04

6.  Activity of mevalonate pathway inhibitors against breast and ovarian cancers in the ATP-based tumour chemosensitivity assay.

Authors:  Louise A Knight; Christian M Kurbacher; Sharon Glaysher; Augusta Fernando; Ralf Reichelt; Susanne Dexel; Uwe Reinhold; Ian A Cree
Journal:  BMC Cancer       Date:  2009-01-28       Impact factor: 4.430

7.  High-throughput 3D screening reveals differences in drug sensitivities between culture models of JIMT1 breast cancer cells.

Authors:  Vesa Hongisto; Sandra Jernström; Vidal Fey; John-Patrick Mpindi; Kristine Kleivi Sahlberg; Olli Kallioniemi; Merja Perälä
Journal:  PLoS One       Date:  2013-10-23       Impact factor: 3.240

8.  Ultrasound-Targeted Microbubble Destruction-Mediated Inhibition of Livin Expression Accelerates Ovarian Cancer Cell Apoptosis.

Authors:  Xiaolin Xu; Shuqin Yu; Xiaoyuan Liu; Ying Feng
Journal:  Genet Res (Camb)       Date:  2021-12-09       Impact factor: 1.588

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.